Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004738
Status:
COMPLETED
Last Update Posted:
2024-05-17
First Post:
2000-02-26
Brief Title:
Genetic Analysis of the Chiari I Malformation
Sponsor:
National Institute of Neurological Disorders and Stroke NINDS
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Genetic Analysis of the Chiari I Malformation
Status:
COMPLETED
Status Verified Date:
2024-05-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to better understand the genetic factors related to the Chiari I malformation In people with this abnormality the lower part of the skull is smaller than normal As a result the lowest part of the brain called the cerebellar tonsils protrudes out of the hole at the bottom of the skull into the spinal canal This study will try to discover the location of the genes responsible for the malformation
Candidates for this study are 1 Patients with Chiari I malformation who also have a family member with the abnormality or a family member with syringomyelia a cyst in the spinal cord that is often associated with the Chiari I malformation 2 Family members of patients with the Chiari I malformation
Participants will have a medical history and physical and neurologic examinations They will undergo magnetic resonance imaging MRI of the brain and cervical neck spinal cord to measure the size of the head and determine the presence of the Chiari I malformation and syringomyelia A small blood sample about 2 tablespoons will be drawn for DNA studies relating to the Chiari I malformation
Candidates for this study are 1 Patients with Chiari I malformation who also have a family member with the abnormality or a family member with syringomyelia a cyst in the spinal cord that is often associated with the Chiari I malformation 2 Family members of patients with the Chiari I malformation
Participants will have a medical history and physical and neurologic examinations They will undergo magnetic resonance imaging MRI of the brain and cervical neck spinal cord to measure the size of the head and determine the presence of the Chiari I malformation and syringomyelia A small blood sample about 2 tablespoons will be drawn for DNA studies relating to the Chiari I malformation
Detailed Description:
Objectives The goal of this study is to establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation and underdevelopment of the bone forming the posterior cranial fossa
Study Population Patients and family members of patients with the Chiari I malformation Because the research institutions are located in the United States and Russia subjects will be recruited predominantly from these countries
Design Human subjects will undergo 1 neurologic examinations 2 head and cervical MRI scans to evaluate for the Chiari I malformation syringomyelia and maldevelopment of the posterior fossa and 3 isolation and analysis of genomic DNA from whole blood for linkage analysis
Outcome Measures Pedigrees will be established based on the MRI findings The Chiari I phenotype will be defined as the caudal portion of the cerebellar tonsils lying greater than or equal to 2 mm below the foramen magnum and underdevelopment of the bone of the posterior fossa will be defined as 1 obliteration of the CSF pathways in the inferior portion of the posterior fossa 2 posterior fossa volume to supratentorial volume ratio of less than or equal to 15 or 3 abnormal shortening of the bones of the skull base Genetic analysis of the genomic DNA will be performed with DNA polymorphic markers to identify chromosomal loci linked to the small posterior fossa phenotype A lod score of 30 equivalent to 10001 odds in favor of linkage will be taken as proof that the Chiari I gene maps to the same genetic region of the human genome as a given DNA marker
Study Population Patients and family members of patients with the Chiari I malformation Because the research institutions are located in the United States and Russia subjects will be recruited predominantly from these countries
Design Human subjects will undergo 1 neurologic examinations 2 head and cervical MRI scans to evaluate for the Chiari I malformation syringomyelia and maldevelopment of the posterior fossa and 3 isolation and analysis of genomic DNA from whole blood for linkage analysis
Outcome Measures Pedigrees will be established based on the MRI findings The Chiari I phenotype will be defined as the caudal portion of the cerebellar tonsils lying greater than or equal to 2 mm below the foramen magnum and underdevelopment of the bone of the posterior fossa will be defined as 1 obliteration of the CSF pathways in the inferior portion of the posterior fossa 2 posterior fossa volume to supratentorial volume ratio of less than or equal to 15 or 3 abnormal shortening of the bones of the skull base Genetic analysis of the genomic DNA will be performed with DNA polymorphic markers to identify chromosomal loci linked to the small posterior fossa phenotype A lod score of 30 equivalent to 10001 odds in favor of linkage will be taken as proof that the Chiari I gene maps to the same genetic region of the human genome as a given DNA marker
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 00-N-0089 | None | None | None |